Related Experiment Video
Updated: Jul 14, 2026

10:44
Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
Published on: October 21, 2016
Versatile Detection of Cellular Protein via Fluorescence Anisotropy
Qing Tang1,2, Yuan-Ping Wei1,3, Ricky Ruiqi Ma1,4
1Institute of Cancer Research, High Throughput Screening Center, Shenzhen Bay Laboratory, Shenzhen, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|July 13, 2026
Summary
We developed Cell Lysate Fluorescence Anisotropy (CFAST), a rapid and economical method for protein detection. CFAST enables robust protein quantification and drug discovery, including identifying small molecule binders and developing targeted protein degraders.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Protein detection is fundamental in life science research.
- Existing methods can be time-consuming or require specialized equipment.
- There is a need for accessible and efficient protein detection techniques.
Purpose of the Study:
- To introduce Cell Lysate Fluorescence Anisotropy (CFAST) as a novel protein detection method.
- To demonstrate the utility of CFAST in quantifying protein levels and identifying molecular interactions.
- To showcase CFAST's application in drug discovery and development.
Main Methods:
- CFAST utilizes a triangulenium dye-labeled nanobody probe to measure fluorescence anisotropy in cell lysates.
- Minimal sample preparation involves centrifugation and nuclease incubation.
- Thermal shift assays coupled with CFAST (thermal shift-CFAST) detect protein-small molecule interactions.
Main Results:
- CFAST accurately detects cellular levels of PARP1, MK2, and GFP.
- Thermal shift-CFAST quantifies dose-dependent inhibitor binding for PARP1 and MK2.
- High-throughput screening with thermal shift-CFAST identified a SOX2 binder and facilitated PROTAC development.
Conclusions:
- CFAST is a versatile, rapid (2-3 hours), and economical alternative for protein detection.
- CFAST facilitates drug discovery by enabling screening of small molecule interactions and development of targeted therapeutics.
- The method is scalable and uses common laboratory resources, making it broadly accessible.

